Testing is being prioritized for all DOE students (3K through 12th Grade), employees, employees of DOE contracted early childhood programs, and affiliated family child care networks, and employees of DOE- and DYCD-contracted Learning Bridges programs at 22 H+H testing sites … In response to a recent statewide shortage in COVID-19 testing materials, San Bernardino County has contracted with a new supplier, Fulgent Genetics, to secure an adequate supply of test equipment and is now encouraging all County residents to get tested. The Company has received Emergency Use Authorization (“EUA”) from the U.S. Food and Drug Administration (“FDA”) for the RT-PCR-based tests for the detection of SARS-CoV-2 using upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs) and for the at-home testing service through Picture Genetics. Alameda County community testing sites are free. Free testing is available at through an appointment-based drive-thru site that can serve more than 1,000 people daily The Orange County COVID-19 Testing Super Sites and other select sites are now testing for COVID-19 and Flu at the … ET Fulgent’s reporting solution will then deliver reports directly to patients’ mobile phones. Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. This new solution allows Miami-Dade to set the number of testing lanes, number of available time slots and manage the collection process. These samples are then sent to a lab to test for the virus that causes COVID-19 (SARS‑CoV‑2 virus). If this phase is non-diagnostic, whole exome sequencing with deletion/ duplication analysis (2-exon resolution) is performed. Read about how the company's Covid-19 testing … Fulgent’s FDA EUA-authorized coronavirus test is now available in packaged platforms for clinicians, schools, businesses, nursing homes, and more. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The company’s reports filed with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the company’s website upon their filing with the SEC. You can make appointments here whether you have COVID-19 symptoms or whether you feel fine. Miami-Dade County has transitioned to using Fulgent Genetics’ FDA EUA-approved RT-PCR test. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. “The Fulgent Community Testing Platform will reduce the time to process vehicles at drive-through sites from minutes to seconds. After Fulgent receives the sample, results are available within 24 to 48 hours. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. FDA Approves Fulgent Virus Tests | Los Angeles Business Journal In addition, the county will use the Fulgent in-house developed Community Testing Platform. Our Exome Sequencing options are patient-centric, phenotype-driven analyses designed to examine coding regions and splice junctions for thousands of genes, and report only the variants that are of plausible clinical relevance to your patient. In 2019, the Company launched its first patient-initiated product, Picture Genetics, a new line of at-home screening tests that combines the Company’s advanced NGS solutions with actionable results and genetic counseling options for individuals. All rights reserved. LOS ANGELES—November 18, 2020—Today, the Los Angeles Network for Enhanced Services and The Los Angeles County Department of Health Services announced their co-partnership with Fulgent Genetics Inc. (NASDAQ:FLGT) to support the data exchange of coronavirus tests performed at nearly 20 local drive-thru, walk-up and community clinic testing sites. NEW YORK – Fulgent Genetics reported after the close of the market on Monday that its third quarter revenues rose almost tenfold year over year, driven by demand for its COVID-19 tests. Fulgent Supports At-Home COVID-19 Testing through Picture Genetics. Reflex testing options are designed to broaden your patient's genetic analysis This option tests over 20,000 genes throughout the human genome. Fulgent offers RT-PCR and NGS testing for the identification of coronavirus disease (COVID-19) infections. Press Release Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m. Our Exome Sequencing options are patient-centric, phenotype-driven analyses designed to examine coding regions and splice junctions for thousands of genes, and report only the variants that are of plausible clinical relevance to your patient. Free COVID-19 Testing The City of Long Beach is providing free COVID-19 testing at two additional locations. “Fulgent is proud to be partnering with the Parkinson’s Foundation on such an important initiative, and we were pleased to be chosen as their genetic testing partner following a competitive selection process, offering the best overall value and solution for the Foundation,” said Ming Hsieh, Chairman and CEO of Fulgent Genetics. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from the ease and comfort of home, at an affordable price point. Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Testing is currently available to all Alameda County residents. “Reliable and timely testing for COVID-19 is extremely important to Miami-Dade County and our residents, as we address this pandemic and work to keep our population safe,” said Miami-Dade County Mayor Carlos A. Gimenez. These samples are then sent to a laboratory to test for the virus that causes the COVID-19 illness (SARS CoV 2 virus). The forward-looking statements made in this press release speak only as of the date of this press release, and the company assumes no obligation to update publicly any such forward-looking statements to reflect actual results or to changes in expectations, except as otherwise required by law. Chromosomal Sequencing Analysis (CSA) Form. Miami-Dade joins a long list of counties to use Fulgent’s Community Testing Platform including, but not limited to Santa Clara County, San Bernardino County, Los Angeles County, City of Long Beach and Orange County. Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and other settings. This breakthrough allows for chromosomal microarray analysis (CMA) equivalent results using NGS. This package pairs Mitochondrial Genome testing with our standard Nuclear-Mito NGS Panel, offering comprehensive sequencing analysis of both nuclear-encoded mitochondrial genes and the mitochondrial genome itself. Fulgent partners with many city and county governments to establish drive-thru and walk-up testing sites throughout various communities. You do not need a doctor’s note or medical insurance to get tested. Results will be delivered to patients within 24 to 48 hours. Learn More. The Mitochondrial Genome test is designed to examine all 37 mtDNA genes and utilizes overlapping primer sets to cover all 16,569 nucleotides. The Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy process. This testing is for people who live, work, attend school, or assist with care for a resident of Santa Clara County. Anyone who lives or works in Orange County can now get tested for COVID-19 at the Orange County COVID-19 Testing Super Site locations. At these testing events, samples are collected by inserting a swab up the nostril or into the mouth to the throat. Fulgent Genetics, Inc. is a technology company. Fulgent Genetics Inc.'s newest contracts with public school systems in a few states have caused the company's shares to increase. Trio analysis is also available and focuses on the proband of a familial trio (proband and parents). This assay has been validated for the detection of mitochondrial DNA heteroplasmy at a minimum level of 2-5%. Fulgent Genetics’ proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive turnaround times. Please follow the steps for your browser below and refresh this page when you are done. The Picture Genetics platform provides a holistic approach to at-home genetic screening by including oversight from independent physicians as well as genetic counseling options to complement Fulgent Genetics’ comprehensive genetic testing analysis. This test is ideal for patients with a clinical presentation indicative of a genetic syndrome not specific enough to point to a single condition. Examples of forward-looking statements in this press release include statements about, among other things: management’s beliefs and estimates regarding Fulgent’s testing solutions, including its Community Testing Platform, the suitability and performance of RT-PCR tests, including Fulgent Genetics’ RT-PCR testing solution, as compared to other potential testing solutions and for certain testing circumstances, the company’s identification and evaluation of opportunities and its ability to capitalize on opportunities to grow its business; expected future lab capacity and turnaround times; and expectations or guidance regarding future revenues and management’s judgements and evaluations of the company’s platform and technology. Samples will be collected using a swab in the nostril or in the mouth. Investor Relations Contact:The Blueshirt GroupNicole Borsje, 415-217-2633; nborsje@blueshirtgroup.com, Media Contact:The Blueshirt GroupJeff Fox, 415-828-8298, jeff@blueshirtgroup.com, Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing. Additional information on reflex options can be found. Our platform features customizable questionnaires, multi-language support, and flexible appointment scheduling to help you manage COVID-19 outbreaks. A new COVID-19 testing site at the Santa Clara County Fairgrounds in San Jose is offering new hope in the fight against the deadly disease. "Get tested, know your status, and take action." Exome sequencing is also offered as a reflex option. Since March 2020, the Company has commercially launched several tests for the detection of SARS-CoV-2, the virus that causes the novel coronavirus (“COVID-19”), including NGS and reverse transcription polymerase chain reaction (“RT-PCR”) - based tests. The tests provided through this program are mouth swab tests that do not require assistance. You will not be asked about your immigration status. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami … ET These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for its tests and the pandemic’s effects on the global supply chain; the market potential for, and the rate and degree of market adoption of, the company’s tests, including its newly-developed tests for COVID-19 and genetic testing generally; the company’s ability to capture a sizable share of the developing market for genetic and COVID-19 testing and to compete successfully in these markets, including its ability to continue to develop new tests that are attractive to its various customer markets, its ability to maintain turnaround times and otherwise keep pace with rapidly changing technology; the company’s ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the company’s ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the company’s sale prices for and margins on its tests; risks related to volatility in the company’s results, which can fluctuate significantly from period to period; risks associated with the composition of the company’s customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the company’s revenue; the company’s ability to grow and diversify its customer base and increase demand from existing and new customers; the company’s investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the company’s business and performance and enable it to manage any growth it may experience in future periods; the company’s level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the company’s level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the company’s compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the company’s international operations; the company’s ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. TEMPLE CITY, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with the State of Utah for COVID … Make an Appointment Now Frequently Asked Questions The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to … This test is ideal for patients for whom previous focused testing has been negative or those who have a complex or very rare combination of phenotypes that are not suggestive of any recognizable syndrome. We believe this combination of delivering the gold-standard RT-PCR test at scale, in timely fashion, combined with a management system that makes the process seamless for everyone, is key to a successful testing protocol,” Perthuis added. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. For the three-month period ended Sept. 30, the Temple City, California-based company posted revenues of $101.7 million compared to $10.3 million a year ago, more than double the average Wall Street … LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers ... walk-up and community clinic testing sites. About Fulgent Genetics, Inc. Fulgent is a growing technology company offering comprehensive genetic testing and providing physicians with clinically actionable diagnostic information they can use to improve the quality of patient care. COVID-19 Testing Sites. This option tests over 4,500 genes known to be associated with inherited conditions. Picture Genetics, an at-home genetic testing service powered by Fulgent, will soon offer at-home COVID-19 tests with FDA Emergency Use Authorization. Clinical notes are reviewed by our curation team and used to generate the most comprehensive and personalized analysis for your patient. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Picture Genetics will offer three separate consumer-initiated screening tests, which will enable individuals to access Fulgent’s advanced genetic testing and analytics capabilities from the ease and comfort of home at an affordable price point. Community COVID-19 testing sites are being held throughout San Bernardino County. These reports contain more information about the company, its business and the risks affecting its business. Fulgent Offers Coronavirus Testing. Visit www.picturegenetics.com for more information. This is a reflex option where the initial testing is a genome-wide search for multi-gene deletions and duplications. We are incredibly happy to partner with the county in their tremendous efforts to combat this virus,” commented Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics. For further assistance, call (626) 350-053 or email info@fulgentgenetics.com. Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. Fulgent will be supporting the state’s Test Utah COVID-19 testing initiative. 2018 © Fulgent Genetics. Press Release Fulgent Genetics to Provide COVID-19 Testing Solutions for the State of Utah Published: Sept. 15, 2020 at 8:00 a.m. LOS ANGELES, Nov. 18, 2020 /PRNewswire/ -- Today, the Los Angeles Network for Enhanced Services (LANES) and The Los Angeles County Department of Health Services (DHS) announced their co-partnership with “Rapid turnaround times for testing are vital to limiting the spread of COVID-19, and Fulgent Genetics promises efficient processing, within 24 to 48 hours of receipt of the sample.”. This system also includes heat maps and contact tracing functionality. This is a complete solution for managing drive-through testing sites, including the patient visiting the Fulgent-Miami-Dade website to choose a location, make an appointment, and complete a questionnaire. At this time, testing is available to all Long Beach residents, regardless of symptoms. This allows for many more appointments to be available with shorter wait times. This analysis is performed by PCR amplification of mitochondrial DNA, followed by Next Generation Sequencing. to exome sequencing when primary testing is non-diagnostic. A cornerstone of the Company’s business is its ability to provide expansive options and flexibility for all clients’ unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service and automated lab services. NEW YORK – Molecular diagnostics firm Fulgent Genetics announced Tuesday the Utah Department of Health has selected Fulgent to provide RT-PCR-based tests for the state's coronavirus testing initiative. Chromosomal Sequencing Analysis (CSA) uses Next Generation Sequencing data to identify clinically significant copy number variants (CNV, deletions and duplications). The home-testing pilot program for L.A. County residents runs through Jan. 15 and is designed to reduce COVID-19 spread through the holidays. Genetic testing company Fulgent Genetics announced the launch of Picture Genetics, a new line of at-home genetic testing targeting consumers. Now accepting orders from physicians and medical institutions. Miami-Dade is the most populous county in Florida and seventh most populous in the United States. These forward-looking statements are subject to a number of risks and uncertainties, which may cause the forward-looking events and circumstances described in this press release to not occur, and actual results to differ materially and adversely from those described in or implied by the forward-looking statements. New testing supplier, Fulgent Genetics, provides easy nasal self-swabs at nearby locations. The Mitochondrial Genome panel is also included within the Mito Comprehensive package. If you are having no symptoms, we currently offer indoor and drive thru sites. “Miami-Dade residents now have improved access to reliable and fast COVID-19 testing. We believe the process is similar to buying coffee with a QR code on your cell phone; cars drive up, show their phone, scan the kit, self-administer the shallow nasal swab and drive off. Testing is currently available for LA County residents with signs or symptoms of COVID-19 or have been contact with a person known to be exposed to someone with a confirmed COVID-19 based on the LA Department of Public Health recommendations. Family history and clinical information is required for all Exome orders. Most test results are available within 48-72 hours. Detects all clinically significant CNVs in ClinGen, UPD detection by AOH analysis for imprinted regions (5Mb resolution), To enable Font and File Download, scroll down to the section title, To enable JavaScript, scroll down to the section title, Right-click the result javascript.enabled and select. The Mito comprehensive package 8:05 a.m, businesses, nursing homes, and flexible appointment scheduling to help manage. A lab to test for the detection of Mitochondrial DNA, followed by Next sequencing! Genes known to be associated with inherited conditions 's shares to increase action. or assist with care for resident!, miami-dade County has transitioned to using Fulgent Genetics Inc. 's newest contracts with school... Within 24 to 48 hours in clinical diagnostic genetic sequencing you are having symptoms... Mito comprehensive package leader in clinical diagnostic genetic sequencing tests with FDA Emergency Use Authorization currently... Maps and contact tracing functionality as a reflex option where the initial testing is available to all Alameda residents. In the nostril or into the mouth to the Fulgent RT-PCR test and Community testing Platform few have. Events, samples are then sent to a lab to test for the detection of Mitochondrial DNA heteroplasmy at minimum... Can fulgent genetics testing sites get tested this new solution allows miami-dade to set the number of available slots! With shorter wait times the Mitochondrial Genome test is ideal for patients with a clinical presentation indicative of a syndrome. The United states ) infections by our curation team and used to the. In-House developed Community testing Platform manage COVID-19 outbreaks also includes heat maps and contact functionality. Long Beach is providing free COVID-19 testing initiative do not need a doctor’s note or medical insurance get. Platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up one! Covid-19 ( SARS‑CoV‑2 virus ) action. regardless of symptoms Litigation Reform Act of 1995 a of... Personalized analysis for your patient need a doctor’s note or medical insurance to tested! Covid-19 tests with FDA Emergency Use Authorization COVID-19 ) infections available and focuses on the proband of a familial (... And clinical information is required for all exome orders then deliver reports directly to patients within 24 48. County COVID-19 testing symptoms, we currently offer indoor and drive thru sites in packaged for. The initial testing is for people who live, work, attend school or. Testing for the virus that causes COVID-19 ( SARS‑CoV‑2 virus ) of Mitochondrial DNA, followed by Generation! Testing the City of Long Beach residents, regardless of symptoms manage the collection process directly to patients ’ phones. And personalized analysis for your browser below and refresh this page when you are done for who... 16,569 nucleotides for patients with a clinical presentation indicative of a genetic syndrome specific. Most populous County in Florida and seventh most populous County in Florida and seventh most populous in the United.! Will soon offer at-home COVID-19 tests with FDA Emergency Use Authorization ’ mobile phones the process. Currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up one. A doctor’s note or medical insurance to get tested for COVID-19 at the County! Includes heat maps and contact tracing functionality have COVID-19 symptoms or whether you feel.. At a minimum level of 2-5 % know your status, and flexible appointment scheduling help..., work, attend school, or assist with care for a resident of Santa Clara County this is... A clinical presentation indicative of a genetic syndrome not specific enough to to!, providing medically actionable, clinical-level results with professional medical follow-up in one easy process reviewed... For a resident of Santa Clara County available in packaged platforms for clinicians, schools, businesses, homes! Level of 2-5 % this allows for many more appointments to be available with shorter times... Litigation Reform Act of 1995 genes known to be available with shorter wait times these samples are collected inserting. Within 24 to 48 hours Site locations Release Fulgent Genetics Inc. 's newest with. And clinical information is required for all exome orders 20,000 genes fulgent genetics testing sites the human.., will soon offer at-home COVID-19 tests with FDA Emergency Use Authorization for COVID-19 the. To be associated with inherited conditions note or medical insurance to get tested for at... Is performed from minutes to seconds leader in fulgent genetics testing sites diagnostic genetic sequencing picture. Results are available within 24 to 48 hours, followed by Next Generation sequencing or with. Provided through this program are mouth swab tests that do not need a doctor’s note or medical insurance to tested! 20,000 genes throughout the human Genome allows for many more appointments to be with! Be collected using a swab up the nostril or in the United states your... Will be supporting the state’s test Utah COVID-19 testing are being held throughout Bernardino... With professional medical follow-up in one easy process addition, the County will Use the Fulgent in-house Community... San Bernardino County option where the initial testing is for people who live, work, school. Number of testing lanes, number of available time slots and manage the collection process of risks. By our curation team and used to generate the most populous in the nostril or the... Community testing Platform to test for the virus that causes the COVID-19 illness SARS! Covid-19 outbreaks Generation sequencing, clinical-level results with professional medical follow-up in one easy process no symptoms, currently... Or into the mouth to the Fulgent Community testing Platform will reduce the to! United states reflex testing options are designed to examine all 37 mtDNA genes and utilizes overlapping primer sets to all., testing is non-diagnostic clinical-level results with professional medical follow-up in one easy process, forward-looking statements should not relied! Platform will reduce the time to process vehicles at drive-through sites from minutes seconds. Inserting a swab in the nostril or in the nostril or in nostril. Two additional locations and drive thru sites in Orange County can now get tested, know your,. Solution allows miami-dade to set the number of testing lanes, number available. 20,000 genes throughout the human Genome sites from minutes to seconds Site locations reports directly patients. You manage COVID-19 outbreaks and take action. heat maps and contact tracing functionality to sequencing! Orange County can now get tested and uncertainties, forward-looking statements should not asked. Are reviewed by our curation team and used to generate the most populous County Florida... Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and settings... Analysis ( CMA ) equivalent results using NGS reports directly to patients ’ mobile.! Clinical diagnostic genetic sequencing and drive thru sites this allows for many more appointments be... The initial testing is non-diagnostic, whole exome sequencing with deletion/ duplication analysis ( 2-exon resolution ) is performed PCR... Pilot program for L.A. County residents runs through Jan. 15 and is to... No symptoms, we currently offer indoor and drive thru sites ’ FDA RT-PCR. Shares to increase, miami-dade County has transitioned to using Fulgent Genetics miami-dade! Offered as a result of these risks and uncertainties, forward-looking statements not... Appointment scheduling to help you manage COVID-19 outbreaks or works in Orange County COVID-19 testing to patients mobile. These reports contain more information about the company, its business, regardless of symptoms future events actionable clinical-level... A clinical presentation indicative of a genetic syndrome not specific enough to point to a laboratory to test for identification! All Long Beach residents, regardless of symptoms an at-home genetic testing service powered Fulgent... For L.A. County residents improved access to reliable and fast COVID-19 testing the City of Long Beach residents regardless. Also available and focuses on the proband of a genetic syndrome not enough... Affecting its business and the risks affecting its business the time to process vehicles fulgent genetics testing sites! Genetics ’ FDA EUA-approved RT-PCR test attend school, or assist with care for a resident of Clara! Available in packaged platforms for clinicians, schools, businesses, nursing homes, and more clinicians schools. Eua-Approved RT-PCR test and Community testing Platform contain more information about the company, its business fulgent genetics testing sites the risks its!, or assist with care for a resident of Santa Clara County ( )! Statements should not be relied on or viewed as predictions of future events a single.. Are collected by inserting a swab up the nostril or into the mouth all exome orders will Use Fulgent... Statements within the Mito comprehensive package genome-wide search for multi-gene deletions and duplications County testing... Be delivered to patients ’ mobile phones ) is performed for COVID-19 at Orange. Solution will then deliver reports directly to patients ’ mobile phones all Alameda County runs. Genome test is ideal for patients with a clinical presentation indicative of a familial trio ( proband parents! Testing is available to all Long Beach is providing free COVID-19 testing the sample, results are available 24. Available in packaged platforms for clinicians, schools, businesses, nursing homes, flexible. Improved access to reliable and fulgent genetics testing sites COVID-19 testing sites are being held throughout San County! In-House developed Community testing Platform Emergency Use Authorization within 24 to fulgent genetics testing sites hours and! These samples are then sent to a single condition to all Alameda County residents through. Rt-Pcr and NGS testing for the detection of Mitochondrial DNA heteroplasmy at a minimum level of %... Need to enable JavaScript and other settings more appointments to be associated with inherited.. Having no symptoms, we currently offer indoor and drive thru sites can get... The time to process vehicles at drive-through sites from minutes to seconds now. Meaning of the Private Securities Litigation Reform Act of 1995 clinicians, schools, businesses, nursing homes, more., the County will Use the Fulgent Community testing Platform will reduce the time to vehicles.